Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines

 : DaxibotulinumtoxinA-lanm for injection (DAXI), a novel botulinum toxin type A formulation, contains a purified 150-kD core neurotoxin (daxibotulinumtoxinA) and proprietary stabilizing peptide (RTP004), and is approved for glabellar line treatment. As with any biologic product, DAXI may potentiall...

Descripción completa

Detalles Bibliográficos
Autores principales: Humphrey, Shannon, Dover, Jeffrey S, Bowsher, Ronald R, Clancy, Amanda, Liu, Yan, Prawdzik, Gregg, Gallagher, Conor J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Special Topic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501746/
https://www.ncbi.nlm.nih.gov/pubmed/37051886
http://dx.doi.org/10.1093/asj/sjad101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501746/
https://www.ncbi.nlm.nih.gov/pubmed/37051886
http://dx.doi.org/10.1093/asj/sjad101

Ejemplares similares